No Data
No Data
AnGes: 2nd quarter (interim period) financial results for December 2024, based on Japanese accounting standards (consolidated).
McDonald's, Isetan Mitsukoshi, Rakuten G, ENEOS HD (9th) (1379-5076)
*The calendar above is tentative and subject to change due to company circumstances. ---------------------------------------August 9 (Friday) <1379> Hokuto <1381> Access <1384> Hokuriyo <1414> Showbond <1417> Miraito One <1429> Japan Aqua <142A> Gingerbread <1431> Livework <14
AnGes has signed a contract with the Gunma Prefecture Health Foundation and Gunma Prefecture to expand newborn screening tests.
On the 31st, Anges <4563> announced that the Hygiene Inspection Office "Anges Clinical Research Laboratory (ACRL)" mainly for rare genetic disease testing will expand newborn screening tests for seven rare genetic diseases (mucopolysaccharidosis I, II, IVA, VI, Pompe disease, Fabry disease targeting only male children, and adrenoleukodystrophy) that are extremely effective for early diagnosis and early treatment for a fee to those who wish to participate. This is related to the public interest foundation "Gunma Prefecture Health".
Will the search for double-digit stocks continue with elimination method vigilance?
The new emerging market this week may continue to be in a tough situation. In the US market over the weekend, the major stock indexes fell sharply due to concerns about economic slowdown, after the market expected the July employment statistics to be lower than expected. The growth market 250 index fell to the level of the COVID-19 shock in March 2020 as of last weekend, so it is likely to further decline this week. Although the yield on 10-year bonds in the US dropped significantly to below 3.8% since December last year, the Australian small/mid cap stocks, which are composed of small and medium-sized companies, may continue to decline.
Emerging markets outlook: be cautious of a one-step decline in the Growth Market 250 index, will continue to search for double-digit stocks by elimination method.
In the current market situation, there is strong selling pressure to avoid risks, and the emerging markets saw a significant decline this week. The rise and fall rates during this period showed that while the Nikkei average fell by -4.67%, the growth market index fell significantly further by -9.62%, and the growth market 250 index fell by -10.36%. Looking back as far as the former Mothers Index, this marked the lowest decline rate since the week of January 1, 2022, of -10.61%. Similar to the primary market, the strong selling pressure to avoid risk is due to factors such as the rapid appreciation of the yen after the meeting of the central banks of Japan, the US and China, and growing concern about a recession in the US economy.
The TOPIX 250 index on the Tokyo Stock Exchange's Growth Market saw its largest decline of the year, as selling in the Prime Market spread.
The Tokyo Stock Exchange Growth Market Index is 807.59, down 29.21 points, with a volume of 0.3 billion 0.91 million shares and a turnover of 109 billion yen. The Tokyo Stock Exchange Growth Market 250 Index is 623.25, down 24.95 points, with a volume of 0.1 billion 60.82 million shares and a turnover of 83.4 billion yen. Today's growth market saw sharp declines in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. There were 58 advancing stocks, 513 declining stocks, and 15 unchanged. The U.S. stock market rose on July 31st. The Dow Jones Industrial Average rose 99.46 points (+0).
No Data